X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (36417) 36417
Newspaper Article (1057) 1057
Newsletter (792) 792
Book Chapter (337) 337
Magazine Article (231) 231
Transcript (42) 42
Book / eBook (32) 32
Dissertation (14) 14
Government Document (14) 14
Reference (14) 14
Book Review (10) 10
Conference Proceeding (6) 6
Publication (6) 6
Trade Publication Article (5) 5
Report (3) 3
Web Resource (3) 3
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25084) 25084
male (15231) 15231
female (13075) 13075
animals (10813) 10813
middle aged (8230) 8230
adult (7842) 7842
gastroenterology & hepatology (6874) 6874
aged (6158) 6158
pharmacology & pharmacy (5285) 5285
gastrointestinal diseases (4781) 4781
treatment outcome (4626) 4626
oncology (4096) 4096
analysis (3809) 3809
research (3663) 3663
care and treatment (3605) 3605
medicine & public health (3560) 3560
health aspects (3506) 3506
mice (3422) 3422
surgery (3380) 3380
cancer (3355) 3355
rats (3250) 3250
risk factors (3092) 3092
gastrointestinal agents (3023) 3023
gastrointestinal agents - therapeutic use (2478) 2478
medicine (2424) 2424
administration, oral (2423) 2423
microbiota (2413) 2413
inflammation (2295) 2295
gastrointestinal tract (2255) 2255
drug therapy (2201) 2201
research article (2192) 2192
double-blind (2180) 2180
adolescent (2178) 2178
intestine (2173) 2173
aged, 80 and over (2163) 2163
gastroenterology (2144) 2144
therapy (2093) 2093
gastrointestinal system (2062) 2062
dose-response relationship, drug (1984) 1984
gastroenterology and hepatology (1971) 1971
retrospective studies (1965) 1965
time factors (1911) 1911
medical research (1899) 1899
gastrointestinal agents - administration & dosage (1864) 1864
chemotherapy (1860) 1860
patients (1822) 1822
studies (1796) 1796
bacteria (1780) 1780
inflammatory bowel disease (1766) 1766
young adult (1765) 1765
multidisciplinary sciences (1762) 1762
microbiology (1761) 1761
abridged index medicus (1750) 1750
prospective studies (1711) 1711
prevention (1647) 1647
immunology (1644) 1644
rodents (1634) 1634
clinical trials (1610) 1610
diagnosis (1597) 1597
management (1588) 1588
digestive system (1580) 1580
probiotics (1569) 1569
disease (1567) 1567
double-blind method (1525) 1525
physiological aspects (1507) 1507
gastrointestinal diseases - chemically induced (1505) 1505
drugs (1504) 1504
internal medicine (1502) 1502
science (1501) 1501
medicine, general & internal (1483) 1483
disease models, animal (1455) 1455
gastrointestinal-tract (1455) 1455
tumors (1455) 1455
dosage and administration (1447) 1447
antibiotics (1446) 1446
metabolism (1436) 1436
inflammatory-bowel-disease (1426) 1426
obesity (1398) 1398
efficacy (1387) 1387
child (1383) 1383
colon (1361) 1361
proteins (1360) 1360
complications and side effects (1353) 1353
anti-inflammatory agents, non-steroidal - adverse effects (1342) 1342
mortality (1325) 1325
usage (1316) 1316
risk (1313) 1313
medicine, experimental (1308) 1308
gastrointestinal surgery (1307) 1307
review (1304) 1304
gastrointestinal motility - drug effects (1272) 1272
diet (1268) 1268
endoscopy (1253) 1253
nutrition & dietetics (1219) 1219
pharmacokinetics (1181) 1181
drug administration schedule (1180) 1180
gastrointestinal tract - microbiology (1174) 1174
hepatology (1172) 1172
diarrhea (1170) 1170
children (1169) 1169
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (37910) 37910
Japanese (348) 348
German (251) 251
Russian (191) 191
French (163) 163
Spanish (145) 145
Italian (65) 65
Chinese (52) 52
Hungarian (33) 33
Danish (22) 22
Korean (17) 17
Polish (13) 13
Swedish (12) 12
Czech (11) 11
Norwegian (10) 10
Hebrew (9) 9
Portuguese (9) 9
Dutch (7) 7
Ukrainian (7) 7
Bulgarian (3) 3
Romanian (3) 3
Slovak (3) 3
Arabic (2) 2
Turkish (2) 2
Croatian (1) 1
Lithuanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 7, pp. 1320 - 1329.e3
Background & Aims Infliximab, a tumor necrosis factor antagonist, is effective for treating patients with Crohn’s disease (CD) and ulcerative colitis (UC). We... 
Gastroenterology and Hepatology | Personalized Medicine | Pharmacokinetics | Therapeutic Drug Monitoring | Monoclonal Antibody | DOSE INTENSIFICATION | MAINTENANCE | THERAPY | CROHNS-DISEASE | EFFICACY | GASTROENTEROLOGY & HEPATOLOGY | ASSOCIATION | WITHDRAWAL | Drug Costs | Recurrence | Crohn Disease - economics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gastrointestinal Agents - administration & dosage | Male | Colitis, Ulcerative - immunology | Gastrointestinal Agents - economics | Antibodies, Monoclonal - blood | Drug Dosage Calculations | Anti-Inflammatory Agents - adverse effects | Infliximab | Crohn Disease - diagnosis | Adult | Anti-Inflammatory Agents - administration & dosage | Anti-Inflammatory Agents - pharmacokinetics | Female | Colitis, Ulcerative - drug therapy | Gastrointestinal Agents - pharmacokinetics | Anti-Inflammatory Agents - economics | Tertiary Care Centers | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Colitis, Ulcerative - blood | Crohn Disease - immunology | Remission Induction | Anti-Inflammatory Agents - blood | Algorithms | Belgium | Colitis, Ulcerative - diagnosis | Antibodies, Monoclonal - administration & dosage | Cost-Benefit Analysis | Crohn Disease - blood | Crohn Disease - drug therapy | Gastrointestinal Agents - adverse effects | Gastrointestinal Agents - blood | Colitis, Ulcerative - economics | Drug Monitoring | Antibodies, Monoclonal - economics | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Care and treatment | Continuing medical education | Consulting services | Ulcerative colitis
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2008, Volume 134, Issue 7, pp. 1861 - 1868
Background & Aims: The benefit to risk ratio of concomitant immunosuppressives with scheduled infliximab (IFX) maintenance therapy for Crohn's disease is an... 
Gastroenterology and Hepatology | RHEUMATOID-ARTHRITIS | ANTIBODIES | MULTICENTER | INFLAMMATORY-BOWEL-DISEASE | THERAPY | SERUM INFLIXIMAB | LYMPHOMA | RISK | INDUCTION | GASTROENTEROLOGY & HEPATOLOGY | SHORT-TERM | Azathioprine - administration & dosage | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gastrointestinal Agents - administration & dosage | Crohn Disease - metabolism | Male | Intestinal Mucosa - drug effects | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Infliximab | Adult | Anti-Inflammatory Agents - administration & dosage | Anti-Inflammatory Agents - pharmacokinetics | Female | Drug Therapy, Combination | France | Gastrointestinal Agents - pharmacokinetics | Immunosuppressive Agents - administration & dosage | Drug Administration Schedule | Mercaptopurine - administration & dosage | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Belgium | Antibodies, Monoclonal - administration & dosage | Crohn Disease - pathology | Crohn Disease - drug therapy | Methotrexate - administration & dosage | Gastrointestinal Agents - adverse effects | Infusions, Intravenous | Intestinal Mucosa - pathology | Clinical trials | Crohn's disease | C-reactive protein | Tumor necrosis factor | Immunotherapy | Life Sciences | Human health and pathology | Hépatology and Gastroenterology
Journal Article
Cancer, ISSN 0008-543X, 2014, Volume 120, Issue 10, pp. 1453 - 1461
Mucositis is a highly significant, and sometimes dose-limiting, toxicity of cancer therapy. The goal of this systematic review was to update the Multinational... 
no | gastrointestinal | mucositis | guidelines | oral | stomatitis | Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) | HEAD | GASTROINTESTINAL MUCOSITIS | ISOO | CELL TRANSPLANTATION | RANDOMIZED-TRIAL | ZINC SUPPLEMENTATION | NECK-CANCER | ONCOLOGY | MUCOSAL INJURY | ORAL MUCOSITIS | DOUBLE-BLIND | LEVEL LASER THERAPY | Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC | Sucralfate - administration & dosage | Humans | Radiotherapy - adverse effects | Antineoplastic Agents - administration & dosage | Protective Agents - therapeutic use | Mucositis - prevention & control | Proctitis - prevention & control | Antineoplastic Agents - adverse effects | Anti-Inflammatory Agents - therapeutic use | Neoplasms - radiotherapy | Intercellular Signaling Peptides and Proteins - administration & dosage | Low-Level Light Therapy | Esophagitis - therapy | Analgesics - therapeutic use | Proctitis - therapy | Anti-Infective Agents - therapeutic use | Evidence-Based Medicine | Mucositis - therapy | Cytokines - administration & dosage | Esophagitis - etiology | Stomatitis - etiology | Mucositis - chemically induced | Oral Hygiene | Anti-Ulcer Agents - administration & dosage | Neoplasms - drug therapy | Phototherapy | Stomatitis - therapy | Proctitis - etiology | Mucositis - etiology | Stomatitis - chemically induced | Esophagitis - prevention & control | Radiation-Protective Agents - therapeutic use | Stomatitis - prevention & control | Amifostine - therapeutic use | Cryotherapy | Hyperbaric Oxygenation | Practice guidelines (Medicine) | Usage | Care and treatment | Mucositis | Analysis | Cancer | Index Medicus | Abridged Index Medicus | Review
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2016, Volume 14, Issue 8, pp. 1120 - 1129.e6
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 150, Issue 2, pp. 380 - 388.e4
Journal Article
Intensive care medicine, ISSN 1432-1238, 2017, Volume 43, Issue 3, pp. 304 - 377
Journal Article